The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
Open accessAbstract
Psoriasis is a common inflammatory skin disease characterized by the appearance of red scaly plaques that can affect any part of the body. High prevalence, chronicity, disfiguration, disability, and associated comorbidity make it a challenge for clinicians of multiple specialties. Likewise, its complex pathogenesis, comprising inflammation, hyperproliferation, and angioneogenesis, intrigues numerous scientific disciplines, namely immunology. From a clinical perspective, the severity of psoriasis is highlighted by its increased mortality, with cardiovascular diseases contributing the highest excess risk. From a scientific point of view, psoriasis has to be considered a systemic inflammatory condition, as blood biomarkers of inflammation are elevated and imaging techniques document sites of inflammation beyond the skin. While the association of psoriasis with cardiovascular diseases is now widely accepted, causes and consequences of this association are controversially discussed. This review comments on epidemiologic, genetic, and mechanistic studies that analyzed the relation between psoriasis and cardiovascular comorbidity. The hypothesis of psoriasis potentially being an independent cardiovascular risk factor, driving atherosclerosis via inflammation-induced endothelial dysfunction, will be discussed. Finally, consequences for the management of psoriasis with the objective to reduce the patients’ excess cardiovascular risk will be pointed out.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · cited 1×
“These conditions are not only well-established major cardiovascular risk factors and therefore incorporated in the Framingham’s Cardiovascular Disease Risk Scores used to predict cardiovascular risk in the general population (33), some of them, namely, smoking (34) and obesity (35), are also risk factors for the devel…”
Background2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Self-citationRisk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · cited 1×
“After adjusting for major cardiovascular risk factors, such as hypertension, diabetes mellitus, and hyperlipidemia, they found a slightly elevated adjusted relative risk for myocardial infarction among patients with mild psoriasis, and a substantially elevated adjusted relative risk among patients with severe psoriasi…”
BackgroundBorst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
Metabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565 · cited 1×
“recently summarized the evidence for obesity, hypertension, diabetes mellitus, dyslipidemia, and the metabolic syndrome as comorbid diseases in psoriasis (8), with the metabolic syndrome essentially representing the combined appearance of obesity, hypertension, insulin resistance, and dyslipidemia (32).”
BackgroundPlatelets in inflammation and atherogenesis
Gawaz, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27196 · Cited by 1,468
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J. L., Kvien, T. K., Dougados, M., Radner, H., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209775 · Cited by 1,380
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
Sherlock, J. P., Joyce-Shaikh, B., Turner, S. P., Chao, C.-C., Sathe, M., Grein, J., Gorman, D. M., Bowman, E. P., McClanahan, T. K., Yearley, J. H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2817 · Cited by 1,060
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
Self-citationT lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943
Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 912
Coates, L. C., Kavanaugh, A., Mease, P. J., Soriano, E. R., Laura Acosta‐Felquer, M., Armstrong, A. W., Bautista‐Molano, W., Boehncke, W., Campbell, W., Cauli, A., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39573 · Cited by 903
Self-citationThe International IBD Genetics Consortium (IIBDGC), Ellinghaus, D., International Genetics of Ankylosing Spondylitis Consortium (IGAS), International PSC Study Group (IPSCSG), Genetic Analysis of Psoriasis Consortium (GAPC), Psoriasis Association Genetics Extension (PAGE), Jostins, L., Spain, S. L., Cortes, A., Bethune, J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3528 · Cited by 751 · cited 1×
“identified seven shared susceptibility loci for psoriasis and Crohn’s disease; they went on to demonstrate a genetic overlap between five seronegative inflammatory diseases, namely psoriasis, Crohn’s disease, ankylosing spondylitis, primary sclerosing cholangitis, and ulcerative colitis (53, 54).”
BackgroundDisease concomitance in psoriasis
Henseler, T., & Christophers, E. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91336-x · Cited by 678
Monocyte-macrophages and T cells in atherosclerosis
Tabas, I., & Lichtman, A. H. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.008 · Cited by 646
The immunogenetics of Psoriasis: A comprehensive review
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.008 · Cited by 616
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 606
The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity
Boehncke, W.-H., Boehncke, S., Tobin, A.-M., & Kirby, B. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01261.x · Cited by 530
Self-citationGenetic insights into common pathways and complex relationships among immune-mediated diseases
Parkes, M., Cortes, A., van Heel, D. A., & Brown, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3502 · Cited by 526
Multiple Roles for Neutrophils in Atherosclerosis
Soehnlein, O. (2012) · Circulation Research · doi:10.1161/circresaha.111.257535 · Cited by 498
Ogdie, A., Yu, Y., Haynes, K., Love, T. J., Maliha, S., Jiang, Y., Troxel, A. B., Hennessy, S., Kimmel, S. E., Margolis, D. J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205675 · Cited by 490 · cited 1×
“Others found the increased risk of such events associated with psoriasis to be comparable with that conferred by diabetes mellitus alone (41) or by rheumatoid arthritis (42).”
ResultThe Th17/Treg imbalance in patients with acute coronary syndrome
Cheng, X., Yu, X., Ding, Y.-J., Fu, Q.-Q., Xie, J.-J., Tang, T.-T., Yao, R., Chen, Y., & Liao, Y.-H. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.009 · Cited by 489
Abuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09941.x · Cited by 472
Armstrong, E. J., Harskamp, C. T., & Armstrong, A. W. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000062 · Cited by 470
Ahlehoff, O., Gislason, G. H., Charlot, M., Jørgensen, C. H., Lindhardsen, J., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02310.x · Cited by 441
Kimball, A. B., Gladman, D., Gelfand, J. M., Gordon, K., Horn, E. J., Korman, N. J., Korver, G., Krueger, G. G., Strober, B. E., & Lebwohl, M. G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.01.006 · Cited by 432
Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice
Smith, E., Prasad, K.-M. R., Butcher, M., Dobrian, A., Kolls, J. K., Ley, K., & Galkina, E. (2010) · Circulation · doi:10.1161/circulationaha.109.924886 · Cited by 421
The Inflammatory Response in Psoriasis: a Comprehensive Review
Deng, Y., Chang, C., & Lu, Q. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8535-x · Cited by 416
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Perez, N., Yasukawa, H., Van Snick, J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090545 · Cited by 408
Convulsions with an Occult Neural-Crest Tumor
(1979) · New England Journal of Medicine · doi:10.1056/nejm197909063011016 · Cited by 404
Nast, A., Gisondi, P., Ormerod, A. D., Saiag, P., Smith, C., Spuls, P. I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13354 · Cited by 399
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384
Psoriasis: a possible risk factor for development of coronary artery calcification
Ludwig, R. J., Herzog, C., Rostock, A., Ochsendorf, F. R., Zollner, T. M., Thaci, D., Kaufmann, R., Vogl, T. J., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07562.x · Cited by 374
Self-citationInhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
Erbel, C., Chen, L., Bea, F., Wangler, S., Celik, S., Lasitschka, F., Wang, Y., Böckler, D., Katus, H. A., & Dengler, T. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901126 · Cited by 358
Ellinghaus, D., Ellinghaus, E., Nair, R. P., Stuart, P. E., Esko, T., Metspalu, A., Debrus, S., Raelson, J. V., Tejasvi, T., Belouchi, M., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.020 · Cited by 348
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Mehta, N. N., Yu, Y., Pinnelas, R., Krishnamoorthy, P., Shin, D. B., Troxel, A. B., & Gelfand, J. M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.03.028 · Cited by 345
Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
Miller, I. M., Ellervik, C., Yazdanyar, S., & Jemec, G. B. E. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.053 · Cited by 318
Horreau, C., Pouplard, C., Brenaut, E., Barnetche, T., Misery, L., Cribier, B., Jullien, D., Aractingi, S., Aubin, F., Joly, P., et al. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12163 · Cited by 313
The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis
Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J., Boehncke, W. H., & Prinz, J. C. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14433 · Cited by 313
Self-citationGisondi, P., Del Giglio, M., Di Francesco, V., Zamboni, M., & Girolomoni, G. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26427 · Cited by 307
Wu, J. J., Poon, K.-Y. T., Channual, J. C., & Shen, A. Y.-J. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2502 · Cited by 304
Samarasekera, E. J., Neilson, J. M., Warren, R. B., Parnham, J., & Smith, C. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.149 · Cited by 298
(1979) · New England Journal of Medicine · doi:10.1056/nejm197909063011015 · Cited by 291
Relationship of Thrombus Healing to Underlying Plaque Morphology in Sudden Coronary Death
Kramer, M. C. A., Rittersma, S. Z. H., de Winter, R. J., Ladich, E. R., Fowler, D. R., Liang, Y.-H., Kutys, R., Carter-Monroe, N., Kolodgie, F. D., van der Wal, A. C., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.007 · Cited by 272
Psoriasis patients show signs of insulin resistance
Boehncke, S., Thaci, D., Beschmann, H., Ludwig, R. J., Ackermann, H., Badenhoop, K., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08190.x · Cited by 248
Self-citationElder, J., Nair, R. P., Guo, S., Henseler, T., Christophers, E., & Voorhees, J. J. (1994) · PubMed · Cited by 239
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.065 · Cited by 226
Späh, F. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08780.x · Cited by 223
Mehta, N. N. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.119 · Cited by 223
Gao, Q., Jiang, Y., Ma, T., Zhu, F., Gao, F., Zhang, P., Guo, C., Wang, Q., Wang, X., Ma, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000116 · Cited by 222
Weidinger, S., Willis-Owen, S. A. G., Kamatani, Y., Baurecht, H., Morar, N., Liang, L., Edser, P., Street, T., Rodriguez, E., O'Regan, G. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt317 · Cited by 219
Madhur, M. S., Funt, S. A., Li, L., Vinh, A., Chen, W., Lob, H. E., Iwakura, Y., Blinder, Y., Rahman, A., Quyyumi, A. A., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.227629 · Cited by 212
Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression
Peled, M., & Fisher, E. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00579 · Cited by 205
Reich, K., Papp, K. A., Matheson, R. T., Tu, J. H., Bissonnette, R., Bourcier, M., Gratton, D., Kunynetz, R. A., Poulin, Y., Rosoph, L. A., et al. (2015) · Experimental Dermatology · doi:10.1111/exd.12710 · Cited by 204
Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis
Balci, D., Balci, A., Karazincir, S., Ucar, E., Iyigun, U., Yalcin, F., Seyfeli, E., Inandi, T., & Egilmez, E. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.02936.x · Cited by 203
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
Strober, B., Teller, C., Yamauchi, P., Miller, J. L., Hooper, M., Yang, Y.-C., & Dann, F. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08628.x · Cited by 200
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
von Stebut, E., Boehncke, W.-H., Ghoreschi, K., Gori, T., Kaya, Z., Thaci, D., & Schäffler, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03096 · Cited by 199
Self-citationAccumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR −/− Mice
van Leeuwen, M., Gijbels, M. J. J., Duijvestijn, A., Smook, M., van de Gaar, M. J., Heeringa, P., de Winther, M. P. J., & Tervaert, J. W. C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.154807 · Cited by 196
Hashmi, S., & Zeng, Q. T. (2006) · Coronary Artery Disease · doi:10.1097/01.mca.0000236288.94553.b4 · Cited by 191
Lago, R., Gómez, R., Lago, F., Gómez-Reino, J., & Gualillo, O. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.004 · Cited by 185
Simon, T., Taleb, S., Danchin, N., Laurans, L., Rousseau, B., Cattan, S., Montely, J.-M., Dubourg, O., Tedgui, A., Kotti, S., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs263 · Cited by 184
Coimbra, S., Oliveira, H., Reis, F., Belo, L., Rocha, S., Quintanilha, A. T., Figueiredo, A., Teixeira, F. J., Castro, E. M. B., Rocha‐Pereira, P., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09992.x · Cited by 183
Parisi, R., Rutter, M. K., Lunt, M., Young, H. S., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.87 · Cited by 181
Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells
Shibata, S., Tada, Y., Hau, C. S., Mitsui, A., Kamata, M., Asano, Y., Sugaya, M., Kadono, T., Masamoto, Y., Kurokawa, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8687 · Cited by 181
Ahlehoff, O., Skov, L., Gislason, G., Lindhardsen, J., Kristensen, S. L., Iversen, L., Lasthein, S., Gniadecki, R., Dam, T. N., Torp‐Pedersen, C., et al. (2013) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02593.x · Cited by 177
Enhanced T-Helper-1 Lymphocyte Activation Patterns in Acute Coronary Syndromes
Methe, H., Brunner, S., Wiegand, D., Nabauer, M., Koglin, J., & Edelman, E. R. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.040 · Cited by 174
Kessler, T., Vilne, B., & Schunkert, H. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506174 · Cited by 173
Serum leptin levels, skin leptin and leptin receptor expression in psoriasis
Çerman, A. A., Bozkurt, S., Sav, A., Tulunay, A., Elbaşı, M. O., & Ergun, T. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08742.x · Cited by 169
Distinct Infiltration of Neutrophils in Lesion Shoulders in ApoE−/− Mice
Rotzius, P., Thams, S., Soehnlein, O., Kenne, E., Tseng, C.-N., Björkström, N. K., Malmberg, K.-J., Lindbom, L., & Eriksson, E. E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090480 · Cited by 159
Inflammation and Atherosclerosis: The End of a Controversy
Hansson, G. K. (2017) · Circulation · doi:10.1161/circulationaha.117.030484 · Cited by 159
Erbel, C., Akhavanpoor, M., Okuyucu, D., Wangler, S., Dietz, A., Zhao, L., Stellos, K., Little, K. M., Lasitschka, F., Doesch, A. O., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400181 · Cited by 158
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
Daudén, E., Castañeda, S., Suárez, C., García‐Campayo, J., Blasco, A. J., Aguilar, M. D., Ferrándiz, C., Puig, L., Sánchez‐Carazo, J. L., & on behalf of the Working Group on Comorbidity in Psoriasis (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12024 · Cited by 144
Update on the genetic architecture of rheumatoid arthritis
Kim, K.-W., Bang, S., Lee, H., & Bae, S. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.176 · Cited by 143
Coimbra, S., Oliveira, H., Reis, F., Belo, L., Rocha, S., Quintanilha, A. T., Figueiredo, A., Teixeira, F. J., Castro, E. M. B., Rocha‐Pereira, P., et al. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03647.x · Cited by 142
Managing comorbid disease in patients with psoriasis
Boehncke, W., Boehncke, S., & Schön, M. P. (2010) · BMJ · doi:10.1136/bmj.b5666 · Cited by 139
Self-citationEffect of Psoriasis Severity on Hypertension Control: A Population-Based Study in the United Kingdom
Takeshita, J., Wang, S., Shin, D. B., Mehta, N. N., Kimmel, S. E., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.2094 · Cited by 139
The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
Abuabara, K., Lee, H., & Kimball, A. B. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10525.x · Cited by 134
Comorbidities in rheumatoid arthritis
Dougados, M. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000267 · Cited by 134
Chronic Plaque Psoriasis Is Associated with Increased Arterial Stiffness
Gisondi, P., Fantin, F., Giglio, M. D., Valbusa, F., Marino, F., Zamboni, M. M., & Girolomoni, G. (2008) · Dermatology · doi:10.1159/000182256 · Cited by 133
Dowlatshahi, E. A., Kavousi, M., Nijsten, T. E. C., Ikram, M. A., Albert Hofman, D., Franco, O. H., & Wakkee, M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.131 · Cited by 131
Andersen, Y. M. F., Egeberg, A., Gislason, G., Hansen, P. R., Skov, L., & Thyssen, J. P. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.01.015 · Cited by 124
IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
Croxford, A. L., Karbach, S. H., Kurschus, F. C., Wörtge, S., Nikolaev, A., Yogev, N., Klebow, S., Schüler, R., Reißig, S., Piotrowski, C., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.404 · Cited by 123
Skin innate immune system in psoriasis: friend or foe?
Nickoloff, B. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8633 · Cited by 121
Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study
Li, W., Han, J., Manson, J. E., Rimm, E. B., Rexrode, K. M., Curhan, G. C., & Qureshi, A. A. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10774.x · Cited by 120
Ludwig, R. J., Schultz, J. E., Boehncke, W., Podda, M., Tandi, C., Krombach, F., Baatz, H., Kaufmann, R., von Andrian, U. H., & Zollner, T. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22318.x · Cited by 120
Self-citationBoehncke, S., Salgo, R., Garbaravičienė, J., Beschmann, H. A., Hardt, K., Diehl, S., Fichtlscherer, S., Thaçi, D., & Boehncke, W. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03947.x · Cited by 120
Self-citationWens, I., Dalgas, U., Stenager, E., & Eijnde, B. O. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513504252 · Cited by 117
Comorbidity in inflammatory bowel disease
López–Sanromán, A., & Muñoz, F. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i22.2723 · Cited by 112
Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography
Armstrong, A. W., Harskamp, C. T., Ledo, L., Rogers, J. H., & Armstrong, E. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.11.025 · Cited by 111
Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional Pathways
Capon, F., Burden, A. D., Trembath, R. C., & Barker, J. N. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.395 · Cited by 110
Association of psoriasis with stroke and myocardial infarction: meta‐analysis of cohort studies
Xu, T., & Zhang, Y. ‐. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12002 · Cited by 108
Montagnani, M., & Quon, M. J. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00092.x · Cited by 102
Bissonnette, R., Harel, F., Krueger, J. G., Guertin, M., Chabot-Blanchet, M., Gonzalez, J., Maari, C., Delorme, I., Lynde, C. W., & Tardif, J. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.02.977 · Cited by 101
Buerger, C., Richter, B., Woth, K., Salgo, R., Malisiewicz, B., Diehl, S., Hardt, K., Boehncke, S., & Boehncke, W. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.123 · Cited by 99
Self-citationThe Union of Vascular and Metabolic Actions of Insulin in Sickness and in Health
Kim, J., Koh, K. K., & Quon, M. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000164044.42910.6b · Cited by 96
Uçak, S., Ekmekci, T., Basat, O., Koslu, A., & Altuntaş, Y. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01499.x · Cited by 95
Endothelial dysfunction and the metabolic syndrome
McVeigh, G. E., & Cohn, J. N. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0059-0 · Cited by 95
Buerger, C., Shirsath, N., Lang, V., Berard, A., Diehl, S., Kaufmann, R., Boehncke, W., & Wolf, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180853 · Cited by 92
Self-citationPsoriasis and cardiovascular events: updating the evidence
Raaby, L., Ahlehoff, O., & de Thurah, A. L. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-016-1712-1 · Cited by 89
Platelet receptors as therapeutic targets: Past, present and future
Jamasbi, J., Ayabe, K., Goto, S., Nieswandt, B., Peter, K., & Siess, W. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-12-0911 · Cited by 87
Κανελλέας, Α., Liapi, C. A., Katoulis, A., Stavropoulos, P., Avgerinou, G., Georgala, S., Economopoulos, T., Stavrianeas, N. G., & Katsambas, A. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2011.04131.x · Cited by 83
Bissonnette, R., Tardif, J., Harel, F., Pressacco, J., Bolduc, C., & Guertin, M. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.975730 · Cited by 83
IL‐17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art
Bernardini, N., Skroza, N., Tolino, E., Mambrin, A., Anzalone, A., Balduzzi, V., Colapietra, D., Marchesiello, A., Michelini, S., Proietti, I., et al. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14695 · Cited by 83
Karadağ, A. S., Yavuz, B., Ertuğrul, D. T., Akın, K. O., Yalçın, A. A., Deveci, O. S., Ata, N., Küçükazman, M., & Dal, K. (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2009.04358.x · Cited by 76
Important roles of platelets as immune cells in the skin
Tamagawa‐Mineoka, R. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.10.003 · Cited by 73
Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3
Ogdie, A., Troxel, A. B., Mehta, N. N., & Gelfand, J. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.218 · Cited by 73
Garbaravičienė, J., Diehl, S., Varwig, D., Bylaitė, M., Ackermann, H., Ludwig, R. J., & Boehncke, W. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01095.x · Cited by 72
Self-citationThe paradoxical role of IL-17 in atherosclerosis
Gong, F., Liu, Z., Liu, J., Zhou, P., Liu, Y., & Lü, X. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.05.007 · Cited by 70
Boehncke, S., Fichtlscherer, S., Salgo, R., Garbaravičienė, J., Beschmann, H. A., Diehl, S., Hardt, K., Thaçi, D., & Boehncke, W. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1108-6 · Cited by 70
Self-citationCardiovascular aspects of psoriasis: an updated review
Pietrzak, A., Bartosińska, J., Chodorowska, G., Szepietowski, J. C., Paluszkiewicz, P., & Schwartz, R. A. (2013) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2012.05584.x · Cited by 68
Lai, Y. C., & Yew, Y. W. (2015) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475415602842 · Cited by 68
Smoking and risk of psoriasis: A nationwide cohort study
Lee, E. J., Han, K., Han, J. H., & Lee, J. H. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.04.015 · Cited by 68
Thyssen, J. P., Halling, A., Andersen, Y. M. F., Gislason, G., Skov, L., & Egeberg, A. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16215 · Cited by 68
Identification of a Missense Variant in LNPEP that Confers Psoriasis Risk
Cheng, H., Li, Y., Zuo, X.-B., Tang, H.-Y., Tang, X.-F., Gao, J.-P., Sheng, Y.-J., Yin, X., Zhou, F.-S., Zhang, C., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.317 · Cited by 67
Radtke, M. A., Mrowietz, U., Feuerhahn, J., Härter, M. C., von Kiedrowski, R., Nast, A., Reich, K., Strömer, K., Wohlrab, J., & Augustin, M. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12643 · Cited by 66
Parsi, K. K., Brezinski, E. A., Lin, T.-C., Li, C., & Armstrong, A. W. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.09.006 · Cited by 66
Psoriasis Is Not a Useful Independent Risk Factor for Cardiovascular Disease
Stern, R. S. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.446 · Cited by 60
Egeberg, A., Thyssen, J. P., Jensen, P., Gislason, G., & Skov, L. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2657 · Cited by 58
Role of psoriasis as independent predictor of cardiovascular disease: A meta-regression analysis
Gaeta, M., Castelvecchio, S., Ricci, C., Pigatto, P. D. M., Pelissero, G., & Cappato, R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.197 · Cited by 57
Boehncke, W., & Schön, M. P. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.08.014 · Cited by 56
Self-citationChen, Y., Chang, Y.-T., Shen, J., Chen, T., Wang, C., Chen, C., & Wu, C. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34335 · Cited by 52
Martínez‐López, A., Blasco‐Morente, G., Pérez‐López, I., Tercedor‐Sánchez, J., & Arias‐Santiago, S. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14841 · Cited by 48
Lorthois, I., Asselineau, D., Seyler, N., & Pouliot, R. (2017) · Mediators of Inflammation · doi:10.1155/2017/7215072 · Cited by 46
Hagert, C., Sareila, O., Kelkka, T., Jalkanen, S., & Holmdahl, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00114 · Cited by 45
Boehncke, W., & Schön, M. P. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00039-1 · Cited by 41
Self-citationGupta, Y., Möller, S., Zillikens, D., Boehncke, W., Ibrahim, S. M., & Ludwig, R. J. (2013) · Experimental Dermatology · doi:10.1111/exd.12192 · Cited by 41
Self-citationMagenta, A., D’Agostino, M., Sileno, S., Vito, L. D., Uras, C., ABENI, D. D., Martino, F., Barillà, F., Madonna, S., Albanesi, C., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8061901 · Cited by 39
Psoriasis and risk of cardiovascular disease: A meta-analysis of cohort studies
Gu, W., Weng, C., Zhao, Y.-T., Liu, Q., & Yin, R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.127 · Cited by 37
Jin, S., Koh, S., Yu, D., Kim, M., Yun, H. T., Lee, D. H., Yoon, H., Cho, S., & Park, H. (2017) · Experimental Dermatology · doi:10.1111/exd.13403 · Cited by 34
Costa, S. E., Marini, O., Bevilacqua, D., DeFranco, A. L., Hou, B., Lonardi, S., Vermi, W., Rodegher, P., Panato, A., Tagliaro, F., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ma0217-054rr · Cited by 32
Psoriasis and Psoriatic Arthritis: Flip Sides of the Coin?
Boehncke, W. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2385 · Cited by 24
Self-citationReview of IL-17 inhibitors for psoriasis
Amin, M., Darji, K., No, D. J., Bhutani, T., & Wu, J. J. (2017) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1395796 · Cited by 24
Overweight and Weight Gain Predict Psoriasis Development in a Population-based Cohort
Danielsen, K., Wilsgaard, T., Olsen, A., & Furberg, A. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2530 · Cited by 23
Does Treatment of Psoriasis Reduce Cardiovascular Comorbidities?
Lebwohl, M. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.06.001 · Cited by 20
Epidermal Insulin Resistance as a Therapeutic Target in Acanthosis nigricans?
Malisiewicz, B., Boehncke, S., Lang, V., Boehncke, W., & Bürger, C. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1778 · Cited by 11
Self-citation
Cited by
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
Self-citationThe Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications
Singh, R., Koppu, S., Perche, P. O., & Feldman, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312793 · Cited by 192
Current Concepts of Psoriasis Immunopathogenesis
Vičić, M., Kaštelan, M., Brajac, I., Sotošek, V., & Massari, L. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111574 · Cited by 163
Psoriasis and Systemic Inflammatory Disorders
Tashiro, T., & Sawada, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084457 · Cited by 104
CCL27 is a crucial regulator of immune homeostasis of the skin and mucosal tissues
Davila, M. L., Xu, M., Huang, C., Gaddes, E. R., Winter, L., Cantorna, M. T., Wang, Y., & Xiong, N. (2022) · iScience · doi:10.1016/j.isci.2022.104426 · Cited by 37
Metadata
- Authors
- Boehncke, W.-H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-04-05
- Volume
- 9
- Pages
- 579-579
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2795583931
- Cited by
- 307
- References
- 147
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.